Michael C. Archer

8.8k total citations · 3 hit papers
167 papers, 6.7k citations indexed

About

Michael C. Archer is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, Michael C. Archer has authored 167 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 31 papers in Cancer Research and 26 papers in Biochemistry. Recurrent topics in Michael C. Archer's work include Cancer, Lipids, and Metabolism (20 papers), Sulfur Compounds in Biology (17 papers) and Water Treatment and Disinfection (11 papers). Michael C. Archer is often cited by papers focused on Cancer, Lipids, and Metabolism (20 papers), Sulfur Compounds in Biology (17 papers) and Water Treatment and Disinfection (11 papers). Michael C. Archer collaborates with scholars based in Canada, United States and United Kingdom. Michael C. Archer's co-authors include Edward L. Giovannucci, Michaël Pollak, Susan M. Gapstur, Richard M. Bergenstal, Douglas Yee, Laurel A. Habel, David M. Harlan, Judith G. Regensteiner, Ahmed El‐Sohemy and Robin E. Duncan and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Michael C. Archer

164 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetes and Cancer

2010 1.8k citations Michael C. Archer et al. profile →
Diabetes and Cancer: A Consensus Report

2010 819 citations Michael C. Archer et al. profile →
The interplay between cell signalling and the mevalonate pathway in cancer

2016 489 citations Michael C. Archer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael C. Archer Canada	38	3.5k	1.7k	1.6k	1.1k	996	167	6.7k
Robert H. Tukey United States	52	3.9k 1.1×	1.1k 0.7×	2.5k 1.6×	695 0.6×	534 0.5×	166	9.6k
Olavi Pelkonen Finland	61	3.9k 1.1×	1.9k 1.1×	2.8k 1.8×	608 0.6×	405 0.4×	291	13.2k
Brian Burchell United Kingdom	62	5.6k 1.6×	758 0.4×	3.2k 2.1×	915 0.9×	1.1k 1.1×	227	12.6k
Jürgen Borlak Germany	49	3.8k 1.1×	1.4k 0.8×	1.0k 0.7×	517 0.5×	729 0.7×	201	8.7k
Thomas R. Tephly United States	54	4.2k 1.2×	634 0.4×	2.3k 1.5×	708 0.7×	572 0.6×	175	10.4k
Hong‐Hao Zhou China	49	3.6k 1.0×	1.5k 0.9×	1.4k 0.9×	478 0.4×	569 0.6×	258	7.8k
Miki Nakajima Japan	60	4.5k 1.3×	2.0k 1.2×	3.0k 1.9×	626 0.6×	480 0.5×	267	11.0k
Harold L. Newmark United States	47	3.2k 0.9×	919 0.5×	1.4k 0.9×	428 0.4×	489 0.5×	87	9.3k
Peter W. Stacpoole United States	53	4.5k 1.3×	1.6k 0.9×	553 0.4×	908 0.8×	917 0.9×	225	9.5k
Kei Nakachi Japan	47	4.0k 1.1×	1.5k 0.9×	1.9k 1.2×	462 0.4×	446 0.4×	155	9.3k

Countries citing papers authored by Michael C. Archer

Since Specialization

Citations

This map shows the geographic impact of Michael C. Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Archer more than expected).

Fields of papers citing papers by Michael C. Archer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Archer. The network helps show where Michael C. Archer may publish in the future.

Co-authorship network of co-authors of Michael C. Archer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. Archer. A scholar is included among the top collaborators of Michael C. Archer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. Archer. Michael C. Archer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Kai, Rudolf Furrer, Michael C. Archer, et al.. (2015). Risk factors for colorectal cancer in man induce aberrant crypt foci in rats: Preliminary findings. Nutrition and Cancer. 68(1). 94–104. 7 indexed citations

Liu, Guodong, Yanmei Li, Jeff C. Liu, et al.. (2013). mda- 7/IL-24 Expression Inhibits Breast Cancer through Upregulation of Growth Arrest-Specific Gene 3 ( gas3 ) and Disruption of β1 Integrin Function. Molecular Cancer Research. 11(6). 593–603. 14 indexed citations

Ealey, Kafi N., Suying Lü, & Michael C. Archer. (2008). Development of aberrant crypt foci in the colons of ob/ob and db/db mice: Evidence that leptin is not a promoter. Molecular Carcinogenesis. 47(9). 667–677. 15 indexed citations

Ealey, Kafi N., et al.. (2008). Reduced susceptibility of muscle-specific insulin receptor knockout mice to colon carcinogenesis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 294(3). G679–G686. 4 indexed citations

Lewis, Simon W., et al.. (2006). The Determination of Morphine in the Larvae of Calliphora stygia using Flow Injection Analysis and HPLC with Chemiluminescence Detection. Journal of Analytical Toxicology. 30(8). 519–523. 30 indexed citations

Ealey, Kafi N., et al.. (2006). Bone abnormalities in adolescent leptin-deficient mice. Regulatory Peptides. 136(1-3). 9–13. 60 indexed citations

Kotsopoulos, Joanne, Alan Medline, Richard Renlund, et al.. (2005). Effects of dietary folate on the development and progression of mammary tumors in rats †. Carcinogenesis. 26(9). 1603–1612. 48 indexed citations

Lü, Suying, et al.. (2005). Cyclooxygenase‐2 overexpression in MCF‐10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. International Journal of Cancer. 116(6). 847–852. 28 indexed citations

Duncan, Robin E., Ahmed El‐Sohemy, & Michael C. Archer. (2004). Delivery of mevalonate to murine extrahepatic tissues via mini-osmotic pumps. Journal of Pharmacological and Toxicological Methods. 50(2). 139–143. 3 indexed citations

10.

Li, Youjun, Rachel R. Higgins, Brian J. Pak, et al.. (2001). p45 ^NFE2 Is a Negative Regulator of Erythroid Proliferation Which Contributes to the Progression of Friend Virus-Induced Erythroleukemias. Molecular and Cellular Biology. 21(1). 73–80. 20 indexed citations

11.

Lü, Suying, et al.. (2001). Susceptibility of lean and obese Zucker rats to tumorigenesis induced by N- methyl- N- nitrosourea. Cancer Letters. 162(2). 155–160. 52 indexed citations

12.

Desaulniers, Daniel, Karen Leingartner, J. Russo, et al.. (2001). Modulatory effects of neonatal exposure to TCDD, or a mixture of PCBs, p,p'-DDT, and p-p'-DDE, on methylnitrosourea-induced mammary tumor development in the rat.. Environmental Health Perspectives. 109(7). 739–747. 43 indexed citations

13.

Smith, Mike U., Francis C. Dane, Michael C. Archer, Randolph S. Devereaux, & Harold Katner. (2000). Students Together Against Negative Decisions (STAND): Evaluation of a School-Based Sexual Risk Reduction Intervention in the Rural South. AIDS Education and Prevention. 12(1). 49–70. 60 indexed citations

14.

Badawi, Alaa, et al.. (1999). Modulation of the Expression of the Cyclooxygenase 1 and 2 Genes in Rat Mammary Glands: Role of Hormonal Status and Dietary Fat. Advances in experimental medicine and biology. 469. 119–124. 5 indexed citations

15.

Kendall, Cyril W.C., et al.. (1998). Thermally oxidized dietary fat and colon carcinogenesis in rodents. Nutrition and Cancer. 30(1). 69–73. 27 indexed citations

16.

Corpet, Denis E., Christian Rémésy, Alan Medline, et al.. (1995). Colonic protein fermentation and promotion of colon carcinogenesis by thermolyzed casein. Nutrition and Cancer. 23(3). 271–281. 49 indexed citations

17.

Archer, Michael C., et al.. (1994). Metabolism of N-nitrosomethylbenzylamine by microsomes from perivenous and periportal hepatocytes. Cancer Letters. 81(1). 27–31. 1 indexed citations

18.

Milligan, Jamie R. & Michael C. Archer. (1988). Alkylation of individual genes in rat liver by the carcinogen N-nitrosodimethylamine. Biochemical and Biophysical Research Communications. 155(1). 14–17. 16 indexed citations

19.

Archer, Michael C.. (1980). Cancer-Causing Agents. Canadian Medical Association Journal. 122(12). 1403–1404. 3 indexed citations

20.

Archer, Michael C., et al.. (1976). Reactions of nitrosamines in the Udenfriend system: Principal products and biological activity. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 35(1). 23–28. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact